Thomas L. Carlisle, M.D., Ph.D.
Clinical Associate Professor
Dr. Carlisle's research interests include interaction of xenobiotic carcinogens with cellular signal transduction pathways, blood coagulation biochemistry including coagulation in malignancy, and laboratory evaluation of clinical coagulation disorders.
Honors, Awards, and Organizations
- Alpha Omega Alpha
- American Association for the Advancement of Science
- American Chemical Society
- American College of Physicians Sigma Xi
Recent Publications
- Lichtman, S.M., Nredzwiecki, D., Barcos, M., Carlisle, T.L., Cooper, M.R., Johnson, J.L., Peterson, B.A.: Phase II Study of Infusional Chemotherapy with Doxorubicin, Vincristine and Etoposide Plus Cyclophosphamide and Prednisone (I-CHOPE) in Resistant Diffuse Aggressive Non-Hodgkins Lymphoma: CALGB 9255. Cancer and Leukemia Group B. Annals of Oncology 11:1141-6, 2000.
- Joyce, D.E., Piett, W.W, Stone, M.S., Carlisle, T.L., Lentz, S.R.: Severe Acquired Protein S Deficiency in a Patient with ANCA-associated Vasculitis. Thrombosis and Hemostasis, 84(5):929-30, 2000.
- Carlisle, T.L., Roncero, C., El Khadir-Mounier, C., Thurmond, D.C., and Goodridge, A.G.: The Malic Enzyme Gene in Chick-Embryo Hepatocytes in Culture: Clofibrate Regulates Responsiveness to Triiodothyronine. J. Lipid Research, 37:2088-2097, 1996.
|
Medical School:
University of Missouri
Graduate School:
Biochemistry
University of Wisconsin
Residency:
The University of Iowa
Fellowship:
The University of Iowa |
